Researchers Discover Molecular Difference in Autistic Brains
Brains of autistic individuals have fewer of a specific kind of glutamate receptor, supporting an idea that autism is driven by a signaling imbalance.
AI Summary
Yale researchers identified a significant molecular distinction in autistic brains; they contain fewer AMPA receptors, which respond to glutamate, the primary excitatory neurotransmitter. This discovery suggests an imbalance in neural signaling could contribute to autism symptoms, offering potential targets for future interventions.